Phreesia (NYSE:PHR) Given New $28.00 Price Target at KeyCorp

Phreesia (NYSE:PHR) had its price target decreased by analysts at KeyCorp from $30.00 to $28.00 in a research note issued to investors on Wednesday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. KeyCorp’s price objective indicates a potential upside of 17.05% from the stock’s current price.

PHR has been the subject of several other reports. Royal Bank of Canada raised shares of Phreesia from a “sector perform” rating to an “outperform” rating and increased their target price for the company from $24.00 to $32.00 in a research note on Wednesday, January 8th. Canaccord Genuity Group raised their price objective on Phreesia from $34.00 to $35.00 and gave the stock a “buy” rating in a research note on Thursday, March 13th. Piper Sandler restated an “overweight” rating and issued a $33.00 target price (up from $31.00) on shares of Phreesia in a report on Wednesday, January 29th. DA Davidson reduced their target price on Phreesia from $36.00 to $34.00 and set a “buy” rating for the company in a report on Monday. Finally, Citigroup lifted their price target on Phreesia from $31.00 to $35.00 and gave the stock a “buy” rating in a research note on Friday, January 10th. Twelve equities research analysts have rated the stock with a buy rating, According to MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of $31.33.

Phreesia Price Performance

Shares of Phreesia stock opened at $23.92 on Wednesday. Phreesia has a 52 week low of $17.07 and a 52 week high of $30.53. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04. The stock has a market cap of $1.41 billion, a PE ratio of -16.27 and a beta of 0.82. The company’s 50-day moving average price is $26.16 and its two-hundred day moving average price is $24.28.

Insider Buying and Selling at Phreesia

In other news, SVP Amy Beth Vanduyn sold 4,720 shares of the business’s stock in a transaction on Tuesday, January 21st. The shares were sold at an average price of $27.31, for a total transaction of $128,903.20. Following the transaction, the senior vice president now directly owns 110,309 shares in the company, valued at $3,012,538.79. The trade was a 4.10 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Balaji Gandhi sold 5,827 shares of the stock in a transaction on Tuesday, January 21st. The stock was sold at an average price of $27.31, for a total value of $159,135.37. Following the sale, the chief financial officer now owns 141,846 shares of the company’s stock, valued at approximately $3,873,814.26. This represents a 3.95 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 177,526 shares of company stock worth $4,908,117. 5.80% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Phreesia

Large investors have recently made changes to their positions in the company. Vanguard Group Inc. raised its position in Phreesia by 1.3% during the fourth quarter. Vanguard Group Inc. now owns 4,823,110 shares of the company’s stock valued at $121,349,000 after acquiring an additional 61,048 shares in the last quarter. Greenhouse Funds LLLP raised its holdings in shares of Phreesia by 27.9% during the 4th quarter. Greenhouse Funds LLLP now owns 2,873,892 shares of the company’s stock valued at $72,307,000 after purchasing an additional 626,579 shares in the last quarter. Franklin Resources Inc. lifted its stake in shares of Phreesia by 0.8% in the 4th quarter. Franklin Resources Inc. now owns 1,509,617 shares of the company’s stock valued at $37,982,000 after purchasing an additional 11,986 shares during the last quarter. State Street Corp boosted its holdings in Phreesia by 7.1% in the third quarter. State Street Corp now owns 1,327,586 shares of the company’s stock worth $30,256,000 after purchasing an additional 88,517 shares in the last quarter. Finally, Deerfield Management Company L.P. Series C increased its position in Phreesia by 133.6% during the fourth quarter. Deerfield Management Company L.P. Series C now owns 1,271,832 shares of the company’s stock worth $31,999,000 after buying an additional 727,384 shares during the last quarter. Institutional investors own 92.10% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.